Latest News Archive
Please select Category, Year, and then Month to display items
25 March 2024
|
Story Anthony Mthembu
|
Photo Lutendo Mabata
Prof Nompumelelo Zondi, the newly appointed Vice-Dean: Research and Postgraduate Studies in the Faculty of The Humanities at the University of the Free State (UFS).
Prof Nompumelelo Zondi has been appointed as Vice-Dean: Research and Postgraduate Studies in the Faculty of The Humanities at the University of the Free State (UFS). Prof Zondi assumed this new role on 1 March 2024 after serving as the Head of Department for African Languages at the University of Pretoria for seven years. “I consider this appointment as an opportunity of growth and learning more about higher education and the Faculty of The Humanities at large,” she said.
Prof Zondi indicates that part of her role is to spearhead the UFS Vision130 within the Faculty of The Humanities, and to ensure that the faculty assists the institution in becoming research-led, student-centred, and globally impactful.
Motivation for assuming this role
One of the primary reasons that led her to consider this role is sharing the knowledge she acquired as part of the Fulbright South African Research Scholar Programme. As a result of that experience and exposure, which went beyond the Ohio State University, she felt it befitting to implement some of the insights she acquired on a bigger scale. Therefore, even though she was impactful in her previous role, Prof Zondi believes that this is an exceptional and more desirable platform to do so. “I feel that I will have easier access to departments within the faculty, while also encouraging and supporting interdepartmental and faculty collaborations,” she explained.
A significant component of Vision 130
He believes that the elements that make up Vision 130 are interrelated. While she considers research central to Vision 130 – as she begins her journey at the UFS, she feels students deserve to be nurtured to further contribute to the university’s impactful research. Thus, student-centredness is the way to go. “I believe that students must be major role players in this Vision130; we must include them in the interactions and discussions that are part of the university’s strategic plan as well as in decision-making processes,” she said. As such, according to Prof Zondi, the more the faculty and the institution care for the students and involve them in Vision130 and in collaborations, the more research outputs the university will achieve.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”